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Differences in Clinical Manifestations and Outcomes between 
Adult and Child Patients with Henoch-Schönlein Purpura
We aimed to investigate differences in clinical manifestations and outcomes between adult 
and child patients with Henoch-Schönlein purpura (HSP), and to analyze the factors 
associated with poor prognosis for HSP nephritis. This retrospective 10-yr study enrolled 
160 patients with HSP who visited Severance Hospital. Purpura was mostly detected in 
lower extremities, but purpura in upper extremities was more frequently observed in adults 
than children (41.7% vs 19.3%). Children had a greater frequency of arthralgia (55.4% vs 
27.1%), while adults had a greater frequency of diarrhea (20% vs 1.6%). Anemia, 
elevated C-reactive protein, and level of IgA were more frequently observed in adults (25% 
vs 7.1%, 65.6% vs 38.4%, 26.3% vs 3.5%). Renal involvement in adults was more severe 
than in children (79.2% vs 30.4%). Chronic renal failure showed a significant difference in 
outcomes of HSP between adults (10.4%) and children (1.8%) after a follow up period of 
an average of 27 months. Furthermore, renal insufficiency at diagnosis was significantly 
related to the progression to chronic renal failure. Our results showed several differences in 
the clinical features of HSP between adults and children. Adults with HSP had a higher 
frequency of renal insufficiency and worse renal outcomes than children. Renal 
insufficiency at diagnosis might be of predictive value for the progression to chronic renal 
failure in HSP patients. 
Keywords: Purpura, Henoch-Schönlein; Child; Adult; Outcome; Prognostic Factor
Yoon Kang,* Jin-su Park,* You-Jung Ha, 
Mi-il Kang, Hee-Jin Park, Sang-Won Lee, 
Soo-Kon Lee, and Yong-Beom Park
Division of Rheumatology, Department of Internal 
Medicine, Institute for Immunology and 
Immunological Diseases, Yonsei University College 
of Medicine, Seoul, Korea
*Yoon Kang and Jin-su Park contributed equally to 
this work.
Received: 17 August 2013
Accepted: 19 November 2013
Address for Correspondence:
Yong-Beom Park, MD
Division of Rheumatology, Department of Internal Medicine, 
Yonsei University College of Medicine, 50 Yonsei-ro, 
Seodaemun-gu, Seoul 120-752, Korea
Tel: +82.2-2228-1967, Fax: +82.2-393-5420 
E-mail: yongbpark@yuhs.ac
http://dx.doi.org/10.3346/jkms.2014.29.2.198 • J Korean Med Sci 2014; 29: 198-203
INTRODUCTION
Henoch-Schönleinpurpura (HSP) is a systemic vasculitis in-
volving small vessels with the deposition of immune complexes 
containing IgA (1). Clinical manifestations show purpuric skin 
lesions, arthralgia, abdominal pain, bleeding, nephritis, neuro-
logic involvement, and pulmonary hemorrhage (2). Nephritis is 
a severe complication of HSP that can proceed to end stage re-
nal failure, and its severity affects long term prognosis (3).
 HSP primarily affects children, and its annual incidence is 
estimated to be 15 cases/100,000 per year (4) in children com-
pared to 1.3 cases/100,000 per year in adults (5). HSP has been 
extensively studied in children but much less focus was given to 
adults.
 Early studies in the 1970s and 1980s suggested a higher per-
centage with renal involvement with poorer renal outcomes in 
adults (6, 7), and the age at onset has been considered to be an-
important factor for disease manifestation, severity and out-
come. There are a few previous studies that have compared the 
disease spectrum as seen in adults with that seen in children (2, 
8-12), but little has been known about its clinical manifestations 
and outcomes in adults until now.
 This study was performed to investigate the differences in 
clinical parameters, laboratory data, and outcomes between 
adults and children with HSP, and to analyze the factors associ-
ated with poor prognosis for HSP nephritis. 
MATERIALS AND METHODS
Patients
We retrospectively evaluated the medical records of 160 patients 
with HSP who visited Severance Hospital, Yonsei University 
Health System in Seoul, Korea, between December 1999 and 
November 2009. The patients were classified into two groups 
according to their age at diagnosis of HSP (13): adults (N = 48, 
> 20 yr old) and children (N = 112, ≤ 20 yr old). All patients ful-
filled the European League against Rheumatism /Paediatric 
Rheumatology International Trials Organisation/Paediatric 
Rheumatology European Society (EULAR/PRINTO/PRES) cri-
teria for HSP, which included having purpura and at least one 
of the four following phenomena: a) abdominal pain; b) histo-
pathology, typically leukocytoclastic vasculitis or proliferative 
glomerulonephritis with IgA deposits; c) arthritis or arthralgia; 
and d) renal involvement (14). On the other hand, the Ameri-
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can College of Rheumatology (ACR) criteria requires 2 of the 
following 4 phenomena: a) palpable purpura, non-thrombocy-
topenic; b) age ≤ 20 yr at disease onset; c) bowel angina; and d) 
histologic changes showing granulocytes in the walls of arteri-
oles or venules (13). We utilized the EULAR/PRINTO/PRES cri-
teria because; a) they do not include age criteria, and the age 
criteria of the ACR are not suitable for adults in our study; b) 
joint symptoms and renal involvement, which are main mani-
festations of HSP, are excluded in the ACR criteria; c) the criteria 
for adults have not been developed yet. We excluded patients 
with cutaneous vasculitis secondary to other collagen vascular 
disease. Predisposing factors for the development of HSP, in-
cluding the previous upper respiratory tract infection (URI), 
were evaluated. Clinical manifestations such as skin, joint, gas-
tro-intestinal, and renal involvement and outcomes such as 
chronic renal failure, persistence of hematuria, or proteinuria 
were assessed. 
Methods
Patients were considered hypertensive if their blood pressure 
was greater than 130/80 mmHg in adults, greater than the 90th 
percentile values for height in children, or when receiving anti-
hypertensive treatments. Renal insufficiency was defined as 
creatinine clearance < 60 mL/min/1.73 m2 (calculated by the 
Modification of Diet in Renal Disease formula in adults and by 
the Schwartz formula in children). Nonnephrotic proteinuria 
was defined as proteinuria ≥ 0.15 g/day, ≤ 3.5 g/day in adults 
and ≥ 4 mg/m2/hr, ≤ 40 mg/m2/hr in children. Nephrotic syn-
drome was defined as proteinuria > 3.5 g/day in adults and 
> 40 mg/m2/hr in children, serum albumin < 2.5 g/dL, with or 
without edema. Microscopic hematuria was defined as > 5 
RBC/HPF, and gross hematuria was defined as > 1,500 RBC/
HPF. If patients complained of well-defined arthralgia or if ar-
thritis was observed on examination, then they were consid-
ered to have joint involvement. Gastrointestinal involvement 
included nausea, vomiting, abdominal pain, diarrhea, and he-
matochezia. 
 Renal outcome at last follow up was assessed as complete re-
covery, relapse, persistent hematuria, persistent proteinuria, or 
progression to chronic renal failure. Relapse was considered 
when a patient who was diagnosed with HSP and who had been 
asymptomatic for at least 1 month presented a new flare of skin 
lesions or other systemic complications. Chronic renal failure 
was defined as creatinine clearance < 60 mL/min/1.73 m2 for 
more than 3 months.
Statistics
Continuous data were described as mean and standard devia-
tion (mean ± SD), and categorical variables as percentages. Chi-
square test or Fisher’s exact test was used to compare categori-
cal variables. Binary logistic regression analysis was used to ex-
plore the independent prognostic factors for poor renal out-
come. All differences were considered significant at P < 0.05. 
Calculations were performed with SPSS (version 17.0; SPSS 
Inc., Chicago, IL, USA).
Ethics statement
This study protocol was approved by the institutional review 
board of Severance Hospital, Seoul, Korea (IRB No.4-2011-0327). 
Informed consent was waived by the board. 
RESULTS
Patient characteristics and predisposing factors
A total of 160 HSP patients were studied (48 adults, 112 chil-
dren). Among them, 56.2% of the adults and 57.1% of the chil-
dren were males. HSP was more frequent during the spring and 
winter in both adults (68.8%) and children (75.1%). URI was a 
common predisposing factor for both adults (22.9%) and chil-
dren (36.6%), and it was not statistically different between adults 
and children. However, prior drug exposure (12.5%) and un-
derlying cancer (10.4%) were identified as predisposing factors 
only in adults (Table 1). Drugs included non-steroidal anti-in-
flammatory drugs (NSAIDs), furosemide, warfarin, and anti-
tuberculosis medications. Cancers were hepatocellular carci-
noma, duodenal cancer, and gastric cancer.
Clinical and laboratory features
Purpura was present in all patients. In both groups, purpura 
was mostly detected in the lower extremities, but purpura in 
the upper extremities was more frequently observed in adults 
than children. Joint involvement occurred less frequently in 
adults. The most frequent pattern observed was oligoarthritis 
affecting the ankles and/or knees. Gastrointestinal involvement 
did not differ between adults and children. The most common 
Table 1. Comparison of demographical data and predisposing factors of HSP in adults 
and children
Parameters
Adults 
(n = 48) (%)
Children
(n = 112) (%)
P
Age (yr)
Mean ± SD
Range
48 ± 14.4
21-83
7.5 ± 4.4
1-20
Sex (male) 27 (56.2) 64 (57.1) 0.917
Season
Spring
Summer
Fall
Winter
13 (27.1)
10 (20.8)
5 (10.4)
20 (41.7)
39 (34.8)
16 (14.3)
13 (11.6)
44 (39.3)
0.338
0.304
0.827
0.778
Predisposing factor
URI
Drug
Cancer
Unknown
11 (22.9)
6 (12.5)
5 (10.4)
26 (54.2)
41 (36.6)
0 (0)
0 (0)
71 (63.3)
0.09
0.001
0.002
0.274
SD, standard deviation; URI, Upper respiratory infection.
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symptom was abdominal pain in both groups. Diarrhea pre-
sented more frequently in adults. Renal involvement presented 
in 79.2% of the adults and in 30.4% of the children, which was a 
significant difference. Microscopic hematuria and a somewhat 
mild renal manifestation, was more frequently observed in chil-
dren. However, severe manifestations such as nephrotic syndro-
me and renal insufficiency occurred more frequently in adults.
 Anemia, elevated C-reactive protein, and an increased level 
of IgA were more frequently observed in adults. Increased plate-
lets occurred more often in children (Table 2).
Treatment and outcome
Immunosuppressant treatment was administered more often 
in adults than in children. The glucocorticoid treatment rate 
was not significantly different between two groups; however, 
cytotoxic drugs such as cyclosporine, cyclophosphamide, and 
azathioprine were prescribed more frequently in adults (12.5%) 
than in children (4.5%).
 The period of follow up did not differ between the adults (mean 
27.6 months) and children (mean 27.5 months). The renal out-
come at last follow up was relatively worse in the adult group. 
The rate of complete recovery in the adult group was signifi-
cantly lower than that in the childhood group (41.7% vs 70.5%). 
Persistent hematuria or proteinuria occurred more frequently 
in adults than in children (58.3% vs 29.5%), and progression to 
chronic renal failure presented more frequently in adults than 
in children (10.4% vs 1.8%) with significance. The relapse rate of 
the two groups did not differ (Table 3).
Prediction of renal outcome
In univariate analysis, age > 20 yr, hypertension, presence of 
abdominal pain, arthralgia, hematuria, proteinuria, nephrotic 
syndrome, renal insufficiency, and anemia were identified as 
prognostic factors for progression to chronic renal failure (Table 
4). Multivariate analyses were derived from the risk factors de-
tected by univariate analysis at P less than 0.05 (Table 5). Renal 
Table 2. Comparison of clinical and laboratory features of HSP in adults and children
Items
Adults 
(n = 48) (%)
Children
(n = 112) (%)
P
Skin involvement
Lower
Upper
Trunk
48 (100)
48 (100)
20 (41.7)
12 (25)
112 (100)
112 (100)
22 (19.3)
23 (20.5)
1.00
1.00
0.004
0.531
Joint involvement 13 (27.1) 62 (55.4) 0.001
GI involvement
Abdominal pain
Nausea, vomiting
Diarrhea
Hematochezia
30 (62.5)
23 (76.7)
5 (16.2)
6 (20)
9 (30)
63 (56.3)
47 (74.6)
3 (4.8)
1 (1.6)
13 (20.6)
0.463
0.829
0.106
0.004
0.320
Renal involvement
Microscopic hematuria
Gross hematuria
Nonnephrotic proteinuria
Nephrotic syndrome
Renal insufficiency
38 (79.2)
32 (84.2)
5 (13.2)
19 (50)
6 (15.8)
6 (15.8)
34 (30.4)
34 (100)
0 (0)
15 (44.1)
3 (8.8)
0 (0)
< 0.001
0.026
0.056
0.618
0.485
0.026
WBC > 11,000/mm3 19/48 (39.6) 55/112 (49.1) 0.268
Hb < 11 g/dL 12/48 (25) 8/112 (7.1) 0.002
Plt > 400,000/mm3 7/48 (14.6) 43/112 (38.4) 0.003
ESR > 20 mm/hr 24/37 (64.9) 19/44 (43.2) 0.051
CRP > 8 mg/dL 27/41 (65.6) 33/86 (38.4) 0.004
IgA > 400 mg/dL 10/38 (26.3) 2/57 (3.5) 0.003
GI, gastrointestinal; WBC, white blood cell; Hb, hemoglobin; Plt, platelet; ESR, eryth-
rocyte sediment rate; CRP, C-reactive protein.
Table 3. Comparison of outcome of HSP in adults and children
Outcomes
Adults 
(n = 48) (%)
Children
(n = 112) (%)
P
Follow up, months
Mean ± SD
Median
Range
27.6 ± 30.3
12
1-111
27.5 ± 33.0
13.5
1-158
Clinical outcomes
Complete recovery
Relapse
Persistent hematuria or proteinuria
Chronic renal failure
20 (41.7)
10 (20.8)
28 (58.3)
5 (10.4)
79 (70.5)
29 (25.9)
33 (29.5)
2 (1.8)
0.001
0.495
0.001
0.026
SD, standard deviation.
Table 4. Univariate analysis of prognostic factors related to progression to chronic 
renal failure
Variables OR 95% CI P
Age > 20 yr 6.40 1.20-34.22 0.03
Female sex 0.51 0.10-2.73 NS
Hypertension 10.00 2.07-48.34 0.004
URI 1.21 0.23-6.47 NS
GI involvement 0.53 0.11-2.43 NS
Hematochezia 1.05 0.12-9.14 NS
Abdominal pain 0.42 0.11-3.41 NS
Diarrhea 4.08 0.42-39.48 NS
Nausea, vomiting 3.48 0.37-32.94 NS
Arthralgia 0.31 0.14-2.39 NS
Gross hematuria 6.21 0.60-64.34 NS
Hematuria 8.2 1.41-43.83 NS
Nephrotic syndrome 18.38 3.34-101.09 0.001
Proteinuria 19.5 2.27-167.36 0.007
Renal insufficiency 100.67 13.01-779.02 < 0.001
Leukocytosis 0.45 0.09-2.39 NS
Anemia 6.00 1.24-29.12 0.026
Thrombocytosis 0.35 0.04-3.02 NS
OR, odds ratio; CI, confidence interval; URI, upper respiratory infection; GI, gastroin-
testinal; NS, not significant.
Table 5. Multivariate analysis of prognostic factors related to progression to chronic 
renal failure
Variables OR 95% CI P
Age > 20 yr 0.49 1.20-34.22 NS
Hypertension 2.69 0.34-21.08 NS
Nephrotic syndrome 0.34 0.01-12.41 NS
Proteinuria 6.88 0.61-78.23 NS
Renal insufficiency 34 3.70-312.09 0.002
Anemia 1.94 0.23-16.59 NS
OR, odds ratio; CI, confidence interval; NS, not significant.
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insufficiency at the time of the diagnosis was found to be an in-
dependent risk factor for progression to chronic renal failure 
(OR, 34; 95% CI, 3.70-312.09; P = 0.002).
DISCUSSION
Our results showed several differences in clinical features and 
outcomes of HSP between adults and children. A slight male 
predominance both in adults and in children in our study was 
consistent with many previous studies (2, 8, 15-19). The inci-
dence of HSP was quite a bit higher in spring and winter and 
URI was common in both adults and children in this study. Pre-
vious studies have shown that the incidence of HSP was highest 
in winter and URI was common (2, 8, 9, 15). This implies a pos-
sible infection etiology. HSP commonly follows URI, and virus-
es such as parvovirus B19 (20) and bacteria such as staphylo-
cocci (21), and streptococci (22) have been suggested as possi-
ble pathogens associated with HSP. Prior drug exposure and 
underlying malignancy as the predisposing factors were shown 
only in adults in this study. IgA immune complex deposition 
resulting in HSP can be caused by exposure to antigens from 
tumors, often adenocarcinomas (23); lymphomas, both non-
Hodgkin’s and Hodgkin’s (23); and IgA myeloma (24). Mitsui et 
al. (25) reported that 24 patients were associated with malig-
nancy among 103 HSP patients, and all of them were adults ex-
cept for one patient. Malignancy might be a different etiologic 
factor between adults and children. The prior drug exposure 
was higher in adults than in children in previous studies (2, 8-10, 
12). Quinolones and clarithromycin (26) have been described 
in association with HSP.
 Purpura was detected in the lower extremities in all patients, 
consistent with previous studies (8, 15). However, purpura in 
the upper extremities was more frequently observed in adults 
than children, unlike the Spanish study (8). Joint involvement 
occurred more frequently in children than in adults in our study, 
while the frequency was similar in previous studies (2, 8-11). 
The common joint involvement pattern was similar with that 
reported in previous studies (2, 11, 18). The frequency and com-
mon symptom of gastrointestinal involvement were compara-
ble with previous studies (2, 8-12). Diarrhea presented more 
frequently in adults, consistent with one study (9). HSP with re-
nal involvement has been reported as 20%-28% in children, 
mostly limited to isolated hematuria or minimal proteinuria 
lasting less than 1 month in 70%-80% of patients (17), in con-
trast to 49%-83% in adults with poorer outcome (18, 25, 27). 
This tendency was also found in our study. Renal involvement 
presented in 79.2% of the adults and in 30.4% of the children. 
Microscopic hematuria, a rather mild renal manifestation, was 
more frequently observed in children, in contrast to severe man-
ifestations such as nephrotic syndrome and renal insufficiency, 
which occurred more frequently in adults. Previous studies 
showed a similar tendency with our results (2, 8-10, 12). Ane-
mia, elevated C-reactive protein, and an increased level of IgA 
were more frequently observed in adults. Increased platelets 
Table 6. Comparison between a previous study (35) and our study
Parameters Hong’s study (35) Our study
Age 
Mean ± SD (yr)
Children†  
5.7 ± 1.8
Adolescent†  
14 ± 2.4
Adult† 
45 ± 14.5
Children  
7.5 ± 4.4
Adult  
48 ± 14.4
Number of enrolled patients 149   38 18 112 48
Mean follow-up (months)     9   13 18   27 27
Sex (M:F) 1.2:1 1.2:1 2:1 1.3:1 1.3:1
Seasonll Fall Except fall Fall Winter Winter
Common predisposing factor URI URI URI URI URI, Drug*, Cancer*
Clinical presentation (%)
Skin 
Upper extremeties
Joint
Gastrointestinal 
Diarrhea
100
  10
  68
  64
100
  16
  50
  61
ND
100
  17
  44
  78
100
  19
    55*
  56
    2
100
    42*
  27
  62
    20*
Renal feature (%)
Nonnephrotic proteinuria
Nephrotic proteinuria
Microscopic hematuria
Gross hematuria
Renal insufficiency
  31
  30
   13‡
   57§
   61*
  48
   17‡
   35§
ND
   83*
  47
   33‡
   20§
  30
  44
    9
100
    0
    0
    79*
  50
  16
  84
  13
    16*
Renal outcome (%)
Remission
Relapse
Persistent hematuria or proteinuria
Renal insufficiency
  20
  41
  80
    0
  26
  22
  70
    4
  0
13
89
13
  71*
  26
  30
    2
   42
   21
    58*
    10*
*P less than 0.05; †Children < 10 yr, adolescent ≥ 10 yr, < 20 yr, adult ≥ 20 yr; ‡Nephrotic proteinuria > 40 mg/m2/hr; §Microscopic or gross hematuria; llMost common season 
at initial presentation. SD, standard deviation; URI, upper respiratory tract infection; HTN, hypertension; ND, no data. 
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occurred more often in children. Laboratory findings were dif-
ferent from study to study and were contradictory (2, 8, 9, 12). 
 Progression to chronic renal failure was reported in 2%-15% 
in children (28, 29) and 8%-68% in adult HSP patients (18, 25, 
27). The renal outcome at last follow up was worse in adult in 
this study. Complete recovery was observed more frequently in 
children than in adults. 10.4% of adults and 1.8% of the children 
progressed to chronic renal failure with statistical significance. 
 We found that older age, hypertension, presence of abdomi-
nal pain, arthralgia, hematuria, proteinuria, nephrotic syndrome, 
renal insufficiency, and anemia at the time of diagnosis were 
prognostic factors for progression to chronic renal failure by 
univariate analysis. Only initial renal insufficiency was found to 
be an independent risk factor for progression to chronic renal 
failure by multivariate analysis. Pillebout et al. (18) reported 
that initial renal insufficiency, proteinuria, and on renal biopsy, 
the degree of interstitial fibrosis, percentage of sclerotic glom-
eruli, and presence of glomeruli with fibrinoid necrosis were 
associated with a severe chronic renal failure. Coppo et al. (17) 
suggested that older age, being female, and mean proteinuria 
levels during follow up were risk factors for dialysis therapy but 
renal biopsy findings were not related. The risk factor, initial re-
nal insufficiency, found in our study is in agreement with Pille-
bout et al.; however, although a renal biopsy was done only in 9 
children and 21 adult patients in our study, the biopsy findings 
were not associated with progression to chronic renal failure, as 
reported by Coppo et al. Our study had a limitation in that the 
renal biopsy findings and mean proteinuria levels during fol-
low-up were not performed by all patients.
 So far, six studies have been published about Korean adult 
HSP (30-35). However, only two studies compared adult and 
children HSP patients (34-35), and one of the two focused their 
investigation on nephritis (34). The analysis by Hong et al. (35) 
was similar to ours; however, they did not find any statistically 
different findings except for renal involvement (Table 6). The 
differences in the number of enrolled adult patients with HSP 
between our study and the one by Hong et al. (35) may explain 
the discrepancy between these findings. We found statistically 
significant differences in clinical manifestations and outcomes 
between Korean adults and children with HSP. This study con-
firmed the observation of different manifestations and outcomes 
between adults and children, particularly in renal involvement. 
Adults with HSP had more frequent renal involvement and 
worse renal outcomes than children. Furthermore, this study 
identified renal insufficiency at the time of the diagnosis as an 
independent risk factor for progression to chronic renal failure. 
More attention and extended follow up will be required in adult 
HSP patients with renal involvement, especially in patients show-
ing renal insufficiency at the time of diagnosis.
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